Main menu

NCM 2023 Houston: Nanopore sequencing reveal structural heterogeneity in canine osteosarcoma


Osteosarcoma (OS) is an aggressive bone malignancy in children and young adults. Implementation and optimization of neoadjuvant chemotherapy led to significant improvements in outcome, but patients with recurrence or metastases at diagnosis continue to have poor outcomes. Whole genome sequencing (WGS) revealed that a hallmark of OS is a highly rearranged genome with complex copy number aberrations. In many respects, canine and human OS are similar. A significant difference is that initial surgery in canine OS allowed us to explore tumor evolution unperturbed by treatment. Here we performed bulk WGS of multiple tumor and normal sites in two canines to analyze the genetic and epigenetic evolution of osteosarcoma. In both canines, structural variation analysis using Severus revealed chromothripsis-like rearrangements in chr11 leading to the deletion of Cdkn2a, a known cell cycle regulator and tumor suppressor. We further detected multi-break rearrangements in chr5, chr8, and chr10. The multi-site analysis identified subclonal structural alterations in TP53 and ATRX genes. Direct phasing of heterozygous germline variants revealed copy-neutral loss-of-heterozygosity events and long identical-by-descent blocks. Haplotype-specific copy-number analysis showed different aneuploidy patterns in both canines, with primarily tetraploid karyotype and partial chromosome arm losses. Our analysis allowed us to identify clonal and subclonal genetic and epigenetic factors involved in tumor progression and evolution in canine OS, which can potentially translate to human disease.

Authors: Mikhail Kolmogorov

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag